BA-277

N/A

Report date: 2023/03/16 14:22:43

NME

Base Information

Drug NameBA-277

Drug Alias NameBA-277

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA

Mechanisms of ActionChondroitin sulfate proteoglycans inhibitorsPhosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN inhibitors

TargetsChondroitin sulfate proteoglycansPhosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN

Therapy Area/IndicationsSpinal Cord Injuries

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBioaxone Biosciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesBioaxone Biosciences Inc

Inactive CompaniesN/A

Active IndicationsSpinal Cord Injuries

Inactive IndicationsN/A

Other Information

ATC CodeN/A